| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |